Professor Adam Frampton

General, Hernia, Gallbladder & HPB Surgeon in London & Surrey

BSc MSc PhD DIC MBBS FRCS (Gen Surg) MRCSEd DipMedTox FRSB

GMC: 6078003

88 Patient reviews Review the doctor

Call

Book online

e-Consultation

Call

Book online

e-Consultation

Professor Adam Frampton areas of expertise:

Professional statement

Prof. Adam Frampton is a consultant general, hepato-pancreato-biliary and robotic surgeon in London and Surrey. He is skilled in treating complex gallstone disease (cholecystectomy), and performing groin and abdominal wall hernia repair, and specialises in liver, pancreatic, and biliary surgery. He has a specialist interest in investigating and treating all benign and cancerous disorders of the liver, pancreas, and biliary-tract.

After qualifying from Imperial College London in 2003, he completed his surgical training in London and Surrey. He was awarded a PhD in 2014 for his work on complex gene interactions in pancreatic cancer. He is Assoc. Professor in Surgical Oncology & Head of Oncology at the University of Surrey.

He underwent basic and higher surgical training in London and Surrey, and became a fellow of the Royal College of Surgeons of England in 2018. During his training he undertook several international observerships in both the USA and Europe, and has gained exceptional experience in his field.

Prof. Frampton is extremely passionate about research, and aims to translate new discoveries directly into improved patient care. He is one of the most knowledgeable specialists in his field and has won numerous awards for his research including the Moynihan prize, the Sir James Fraser Travelling Fellowship and the Hunterian Professorship. He is currently a tenured Assoc. Professor in Surgical Oncology and Head of Oncology at the University of Surrey where he leads a laboratory group and supervises BSc, MSc, MD and PhD students.

His current research includes investigating the molecular aspects of pancreatic, liver and biliary-tract cancers, including the development of clinically useful biomarkers and targeted anti-cancer treatments, and understanding the tumour microenvironment and mechanisms of metastasis (cancer spread), topics on which he regularly publishes his findings in peer-reviewed journals.

Prof. Frampton’s research is “cutting-edge”, and consequently he offers a highly analytical and evidence-based approach for his patients.

Reviews

Treatments

Articles

Download

Images

Videos

Credentials

GMC: ‍6078003

Professional experience

• More than 20 years of experience
• Consultant in General and Hepato-Pancreato-Biliary Surgery, Royal Surrey NHS Foundation Trust
• Consultant in General and Hepato-Pancreato-Biliary Surgery, Nuffield Health Guildford Hospital
• Consultant in General and Hepato-Pancreato-Biliary Surgery, New Victoria Hospital, Kingston
• Consultant in General and Hepato-Pancreato-Biliary Surgery, Cromwell Hospital, London

...

Sub-specialties

• Hernia
• Pancreas
• Liver
• Gallbladder
• Bile duct

...

Positions in public associations

• Assistant Staff Editor, Annals of Medicine and Surgery (2014 - present)
• Section Editor, Cancers, open access journal of oncology (2019 - present)

Teaching posts

• Honorary Clinical Lecturer and Laboratory Group Leader, Imperial College London (2014 - present)
• Vice Chancellor's Fellow, senior lecturer in surgical oncology and laboratory group leader, University of Surrey (2019 - present)

Education

• FRCS (Gen Surg), Fellow of Royal College of Surgeons England (2018)
• Hunterian Professorship, Royal College of Surgeons England (2018)
• FRSB, Royal Society of Biology (2017)
• PhD, Molecular oncology, Imperial College London (2014)
• MSc (Merit), General Surgical Practice, University of Kent (2011)
• MRCSEd, Member of Royal College of Surgeons Edinburgh (2009)
• MB BS, Imperial College London School of Medicine (2003)
• BSc (Hons), Pharmacology and Toxicology, Imperial College London (2002)

...

Publications and conferences

• Sarah Blacker, Rajiv P. Lahiri, Mary Phillips, Graham Pinn, Tim D. Pencavel, Rajesh Kumar, Angela T. Riga, Tim R. Worthington, Nariman D. Karanjia, Adam E. Frampton. Which patients benefit from preoperative biliary drainage in resectable pancreatic cancer? Expert Review of Gastroenterology & Hepatology. DOI: 10.1080/17474124.2021.1915127
• Frilling A, Clift AK, Frampton AE, Bomanji J, Kaemmerer D, Al-Nahhas A, Alsafi A, Kidd M, Modlin IM, Hoersch D, Baum RP. A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms. Int J Med Sci. 2021 Mar 19;18(10):2166-2175.
• View some of Mr Frampton's research on ResearchGate

...

Prizes and awards

• Starter Grant, awarded by Oxsonics, Oxford (2021)
• Faculty Research Support Fund grant, University of Surrey (2021)
• One Year Research Fellowship, Royal College of Surgeons England (2020)
• Alex Simpson-Smith Travel Award (2017)
• Moynihan Prize (2017)
• Hunterian Professorship, Royal College of Surgeons England (2018)
• Sir James Fraser Travelling Fellowship in General Surgery, Royal College of Surgeons Edinburgh (2017)

...

Professional membership

• Association of Upper GI Surgeons (AUGIS)
• Royal Society for Biology (RSB)
• Society for Surgery of the Alimentary Tract (SSAT), USA
• British Association of Surgical Oncologists (BASO)
• European Pancreatic Club (EPC) & Pancreatic Society
• The Association of Surgeons in Training (ASIT)
• The Royal Society of Medicine (RSM)

...

Languages spoken

English